Journal article
IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma
Carrie Van Der Weyden, Martine Bagot, Paul Neeson, Phil K Darcy, H Miles Prince
Expert Opinion on Investigational Drugs | TAYLOR & FRANCIS LTD | Published : 2018